Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gsalpha |
Human prostate cancer cell line that overexpresses the Gs-alpha protein (derivat of PC3) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. L. Omara-Opyene et al., Lab Invest., 2004 Jul; 84(7):894-907 | |||
Gsalpha-QL |
Human prostate cancer cell line that overexpresses the Gs-alpha protein (derivat of PC3) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | K. A. Iczkowski et al., Anticancer Res, Jul 2006; 26: 2863 - 2872 | Link | ||
GSC-1 |
Human glioma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Nabissi et al., Int. J. Cancer, 2015, 137: 1855-1869 | Link | ||
GSC-1 |
Human glioblastoma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Int. J. of Cancer, 2012, 131: E1067–E1077, DOI: 10.1002/ijc.27588 | Link | ||
GSC-30 |
Human glioma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Nabissi et al., Int. J. Cancer, 2015, 137: 1855-1869 | Link | ||
GSC-30 |
Human glioblastoma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Int. J. of Cancer, 2012, 131: E1067–E1077, DOI: 10.1002/ijc.27588 | Link | ||
GSC-83 |
Human glioma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Nabissi et al., Int. J. Cancer, 2015, 137: 1855-1869 | Link | ||
GSC-83 |
Human glioblastoma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Int. J. of Cancer, 2012, 131: E1067–E1077, DOI: 10.1002/ijc.27588 | Link | ||
hASMC |
Human arterial smooth muscle cells | Human | vasculature | unknown | siRNA | RNA-Interference | Metafectene SI | publication | M. R. Schroeter et al., Cardiovasc Res, Aug 2013; 99: 555 - 565 | Link | |||
hBCSCs |
Human breast cancer stem cells (from xenografts of human breast cancers) | Human | respiratory system | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | W.-W. Chang et al., Breast Cancer Res., 2013, 15: R39, doi:10.1186/bcr3423 | Link | ||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. J. Lee et al., Mol. Therapy, 2017, 26(3): 845-859, doi.org/10.1016/j.ymthe.2017.12.015 | Link | ||
hCMEC/D3 |
Human brain-derived microvascular endothelial cells | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Krishnan et al.,Oncotarget, 2015, 6(26): 22480-22495 | Link | ||
HCT-116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob-Schwarzl et al., Oncotarget, 2017, 8(60): 101224-101243 | Link | |
HCT-8 |
Human ileocecal colorectal adenocarcinoma cell line | ATCC CCL-244 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | publication | S. Möltgen et al., Cells, 2020, 9, 1322, doi:10.3390/cells9061322 | Link | |
HCT-8 |
Human ileocecal colorectal adenocarcinoma cell line | ATCC CCL-244 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | application note | ![]() |
||
HCT-8ox |
Human oxaliplatin-resistant ileocecal colorectal adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | application note | ![]() |
|||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Nir et al., 2013, US 2013/0072448 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | O. D. K. Maddocks et al., Natur, 2013, 542 (493), doi:10.1038/nature11743 | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Diaz-Moralli et al., Oncotarget, 2016, 7 (32): 51876-51897 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. Zhou et al., Cell Death and Differentiation, 2015, 22:755-766; doi:10.1038/cdd.2014.167 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | Q. Zhang et al., eLife Sci, Jan 2014; 3: e03077 | Link |